PNNL contributes to a nationwide research consortium investigating the molecular mechanisms triggered by endurance training.

New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.

The nested nanoPOTS chip is the next generation of technology developed at PNNL to prepare single cells for proteomics.